Maio, M., Grob, J., Aamdal, S., Bondarenko, I., Robert, C., Thomas, L., . . . Wolchok, J. D. (2015). Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial. J Clin Oncol.
Citação norma ChicagoMaio, Michele, et al. "Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial." J Clin Oncol 2015.
Citação norma MLAMaio, Michele, et al. "Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial." J Clin Oncol 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.